159 related articles for article (PubMed ID: 22172707)
1. Effects of 5-fluorouracil and gemcitabine on a breast cancer cell line (MCF-7) via the JAK/STAT pathway.
Uluer ET; Aydemir I; Inan S; Ozbilgin K; Vatansever HS
Acta Histochem; 2012 Nov; 114(7):641-6. PubMed ID: 22172707
[TBL] [Abstract][Full Text] [Related]
2. Cucurbitacin B induces apoptosis by inhibition of the JAK/STAT pathway and potentiates antiproliferative effects of gemcitabine on pancreatic cancer cells.
Thoennissen NH; Iwanski GB; Doan NB; Okamoto R; Lin P; Abbassi S; Song JH; Yin D; Toh M; Xie WD; Said JW; Koeffler HP
Cancer Res; 2009 Jul; 69(14):5876-84. PubMed ID: 19605406
[TBL] [Abstract][Full Text] [Related]
3. JAK/STAT/SOCS-signaling pathway and colon and rectal cancer.
Slattery ML; Lundgreen A; Kadlubar SA; Bondurant KL; Wolff RK
Mol Carcinog; 2013 Feb; 52(2):155-66. PubMed ID: 22121102
[TBL] [Abstract][Full Text] [Related]
4. Jak-Stat signaling pathway may play a role in the pathogenesis of cholesteatoma.
Eskiizmir G; Seda Vatansever H; Ozgür E; Aslan A; Tanyeri G; Gözüaçık D; Kemal Özbilgin M; Cingi C
Am J Otolaryngol; 2014; 35(2):130-6. PubMed ID: 24321752
[TBL] [Abstract][Full Text] [Related]
5. Defining the role of the JAK-STAT pathway in head and neck and thoracic malignancies: implications for future therapeutic approaches.
Lai SY; Johnson FM
Drug Resist Updat; 2010 Jun; 13(3):67-78. PubMed ID: 20471303
[TBL] [Abstract][Full Text] [Related]
6. Targeting the JAK/STAT Signaling Pathway for Breast Cancer.
Shao F; Pang X; Baeg GH
Curr Med Chem; 2021; 28(25):5137-5151. PubMed ID: 33290193
[TBL] [Abstract][Full Text] [Related]
7. Sequential activation of JAKs, STATs and xanthine dehydrogenase/oxidase by hypoxia in lung microvascular endothelial cells.
Wang G; Qian P; Jackson FR; Qian G; Wu G
Int J Biochem Cell Biol; 2008; 40(3):461-70. PubMed ID: 17920330
[TBL] [Abstract][Full Text] [Related]
8. Identification of the JAK-STAT pathway in canine splenic hemangiosarcoma, thyroid carcinoma, mast cell tumor, and anal sac adenocarcinoma.
Cletzer E; Klahn S; Dervisis N; LeRoith T
Vet Immunol Immunopathol; 2020 Feb; 220():109996. PubMed ID: 31958674
[TBL] [Abstract][Full Text] [Related]
9. Role of the JAK/STAT pathway in a streptozotocin-induced diabetic retinopathy mouse model.
Cho CH; Roh KH; Lim NY; Park SJ; Park S; Kim HW
Graefes Arch Clin Exp Ophthalmol; 2022 Nov; 260(11):3553-3563. PubMed ID: 35599279
[TBL] [Abstract][Full Text] [Related]
10. Mining for JAK-STAT mutations in cancer.
Constantinescu SN; Girardot M; Pecquet C
Trends Biochem Sci; 2008 Mar; 33(3):122-31. PubMed ID: 18291658
[TBL] [Abstract][Full Text] [Related]
11. 5-Fluorouracil or gemcitabine combined with adenoviral-mediated reintroduction of p16INK4A greatly enhanced cytotoxicity in Panc-1 pancreatic adenocarcinoma cells.
Halloran CM; Ghaneh P; Shore S; Greenhalf W; Zumstein L; Wilson D; Neoptolemos JP; Costello E
J Gene Med; 2004 May; 6(5):514-25. PubMed ID: 15133762
[TBL] [Abstract][Full Text] [Related]
12. GRAMD1B regulates cell migration in breast cancer cells through JAK/STAT and Akt signaling.
Khanna P; Lee JS; Sereemaspun A; Lee H; Baeg GH
Sci Rep; 2018 Jun; 8(1):9511. PubMed ID: 29934528
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of ERα/ERK/P62 cascades induces "autophagic switch" in the estrogen receptor-positive breast cancer cells exposed to gemcitabine.
Shen P; Chen M; He M; Chen L; Song Y; Xiao P; Wan X; Dai F; Pan T; Wang Q
Oncotarget; 2016 Jul; 7(30):48501-48516. PubMed ID: 27384485
[TBL] [Abstract][Full Text] [Related]
14. NFIC1 suppresses migration and invasion of breast cancer cells through interferon-mediated Jak-STAT pathway.
Zhang J; Fan M; Jin C; Wang Z; Yao Y; Shi Y; Hu X; Wan Y
Arch Biochem Biophys; 2022 Sep; 727():109346. PubMed ID: 35798053
[TBL] [Abstract][Full Text] [Related]
15. Hedgehog inhibitor decreases chemosensitivity to 5-fluorouracil and gemcitabine under hypoxic conditions in pancreatic cancer.
Onishi H; Morifuji Y; Kai M; Suyama K; Iwasaki H; Katano M
Cancer Sci; 2012 Jul; 103(7):1272-9. PubMed ID: 22486854
[TBL] [Abstract][Full Text] [Related]
16. Deregulation in STAT signaling is important for cutaneous T-cell lymphoma (CTCL) pathogenesis and cancer progression.
Netchiporouk E; Litvinov IV; Moreau L; Gilbert M; Sasseville D; Duvic M
Cell Cycle; 2014; 13(21):3331-5. PubMed ID: 25485578
[TBL] [Abstract][Full Text] [Related]
17. Immunolocalisation of the janus kinases (JAK)--signal transducers and activators of transcription (STAT) pathway in human epidermis.
Nishio H; Matsui K; Tsuji H; Tamura A; Suzuki K
J Anat; 2001 May; 198(Pt 5):581-9. PubMed ID: 11430697
[TBL] [Abstract][Full Text] [Related]
18. Expression of the Selected Proteins of JAK/STAT Signaling Pathway in Diseases with Oral Mucosa Involvement.
Ociepa K; Danilewicz M; Wągrowska-Danilewicz M; Peterson-Jęckowska R; Wójcicka-Rubin A; Lewkowicz N; Zajdel R; Żebrowska A
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613766
[TBL] [Abstract][Full Text] [Related]
19. Expression of the JAK/STAT Signaling Pathway in Bullous Pemphigoid and Dermatitis Herpetiformis.
Juczynska K; Wozniacka A; Waszczykowska E; Danilewicz M; Wagrowska-Danilewicz M; Wieczfinska J; Pawliczak R; Zebrowska A
Mediators Inflamm; 2017; 2017():6716419. PubMed ID: 29203970
[TBL] [Abstract][Full Text] [Related]
20. JAK-STAT and JAK-PI3K-mTORC1 pathways regulate telomerase transcriptionally and posttranslationally in ATL cells.
Yamada O; Ozaki K; Akiyama M; Kawauchi K
Mol Cancer Ther; 2012 May; 11(5):1112-21. PubMed ID: 22402124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
